Hosted on MSN1mon
Supernus wins FDA approval for Parkinson’s pump on fourth trySupernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride ... The company acquired Onapgo, previously known as SPN-830, from US WorldMeds in 2020.
formerly known as SPN-830, as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s disease (PD). Supernus will ...
Supernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial
formerly known as SPN-830, as the first and only subcutaneous apomorphine infusion device for motor fluctuations in adults with advanced Parkinson’s disease. Supernus will make ONAPGO available ...
Parkinson’s Disease Companies are UCB Biopharma SRL, Novartis, Annovis Bio, Supernus ... SPN-830 is an SC formulation of apomorphine delivered continuously through a portable electronic infusion ...
Supernus Pharmaceuticals has won Food and Drug Administration approval for its Onapgo device to treat patients with Parkinson's disease. Supernus on Tuesday said the FDA green light makes Onapgo ...
formerly known as SPN-830, as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's disease (PD). Supernus will make ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results